Evaluation of intestinal necrosis with laser Doppler in experimental mesenteric ischemia model

Nurullah Aksoy1, Davut Sinan Kaplan2, Mustafa Orkmez3

  • 1Department of General Surgery, International Adn Hospital, Gaziantep-Türki̇ye.

Abstract

Insights

Creatine kinase and lactate dehydrogenase (LDH) show promise as biomarkers for acute mesenteric ischemia (AMI). Laser Doppler flowmetry aids in surgical decisions by identifying compromised bowel tissue.

Area of Science:

  • Gastroenterology
  • Surgical Innovation
  • Biochemical Diagnostics

Background:

  • Acute mesenteric ischemia (AMI) presents a significant clinical challenge with high mortality.
  • Current diagnostic tools for AMI often lead to delayed detection and treatment.
  • There is a need for improved methods to diagnose and manage ischemic bowel conditions.

Purpose of the Study:

  • To evaluate the diagnostic utility of creatine kinase, C-reactive protein (CRP), and lactate dehydrogenase (LDH) in a rat model of AMI.
  • To assess the effectiveness of laser Doppler flowmetry in detecting bowel ischemia.
  • To compare biochemical markers and blood flow measurements with pathological scoring of intestinal viability.

Main Methods:

  • Experimental induction of mesenteric ischemia in rats for varying durations (1-4 hours).
  • Measurement of blood flow using laser Doppler.
  • Analysis of serum creatine kinase, CRP, and LDH levels.
  • Assessment of intestinal viability using the Chiu ischemia scoring system.

Main Results:

  • Laser Doppler measurements effectively correlated with the duration and severity of mesenteric ischemia.
  • No significant correlation was observed between CRP levels and ischemia duration.
  • Creatine kinase and LDH levels were significantly elevated in cases of prolonged ischemia (3-4 hours).

Conclusions:

  • Creatine kinase and LDH may serve as valuable biomarkers for diagnosing AMI.
  • Laser Doppler flowmetry is a reliable tool for identifying ischemic bowel segments during surgery.
  • Combined use of biochemical markers and blood flow assessment can improve AMI management.

Related Concept Videos